Jaclyn M W Hughto
Overview
Explore the profile of Jaclyn M W Hughto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehta N, Noh M, Agenor M, Murchison G, Hughto J, Nelson K, et al.
AIDS Care
. 2025 Feb;
:1-9.
PMID: 39955619
Transgender and nonbinary young adults in the United States (U.S.) experience disproportionately high rates of HIV and face unique barriers to accessing HIV testing, a key component of HIV prevention....
2.
Corman J, Hughto J, Shireman T, Baker K, Steinle K, Forcier M
J Med Internet Res
. 2025 Feb;
27:e64017.
PMID: 39951700
Background: Gender-affirming hormone therapy (GAHT) has shown potential for improving mental health outcomes among transgender and gender-diverse adults. How clinical outcomes change among adults receiving GAHT via telehealth across the...
3.
Hughto J, Varma H, Yee K, Babbs G, Hughes L, Pletta D, et al.
AIDS Care
. 2025 Jan;
:1-12.
PMID: 39886758
Although HIV is more prevalent among transgender and gender-diverse individuals than cisgender people, a dearth of research has compared the HIV-related care engagement of these populations. Using 2008-2017 Medicare data,...
4.
Pletta D, Mayer K, Chen J, Hughto J, Keuroghlian A, Radix A, et al.
Transgend Health
. 2024 Dec;
9(6):508-515.
PMID: 39735371
Purpose: Transgender and nonbinary adults (TNB) are disproportionately burdened by sexually transmitted infections (STI) and the human immunodeficiency virus (HIV). This study investigated whether gender-affirming hormone therapy was associated with...
5.
Babbs G, Mulcahy A, Ellison J, Varma H, Pletta D, Yee K, et al.
Disabil Health J
. 2024 Dec;
18(2):101764.
PMID: 39701841
Background: Transgender and gender diverse (TGD) adults experience disability at twice the rate of cisgender (non-TGD) adults in the US. TGD people of color and low-income TGD people experience intersecting...
6.
Rapisarda S, Silcox J, Case P, Palacios W, Stopka T, Zaragoza S, et al.
AIDS Behav
. 2024 Dec;
29(2):584-588.
PMID: 39676088
No abstract available.
7.
Hughto J, Hughes L, Nelson K, Perry N, Mimiaga M, Biello K, et al.
J Subst Use Addict Treat
. 2024 Dec;
169:209602.
PMID: 39672333
Introduction: Opioid use disorder is a chronic, relapsing disease and a major source of morbidity and mortality in the U.S. Medications for opioid use disorder (MOUD) have been shown to...
8.
Hughto J, Kelly P, Vento S, Pletta D, Noh M, Silcox J, et al.
Drug Alcohol Depend
. 2024 Nov;
266:112501.
PMID: 39608288
Purpose: To explore people who use stimulants' (PWUS) stimulant overdose experiences and identify factors associated with calling 911 for personal and witnessed stimulant overdoses. Methods: From 2022-2023, 222 people in...
9.
Rapisarda S, Silcox J, Case P, Palacios W, Stopka T, Zaragoza S, et al.
AIDS Behav
. 2024 Nov;
29(2):562-583.
PMID: 39511061
Illicitly manufactured fentanyl within the drug supply has substantially increased opioid-related overdose deaths and driven infectious disease outbreaks among people who use drugs (PWUD). Local jurisdictions often lack the data...
10.
Wolfe H, Hughto J, Siegel J, Fix G, Poteat T, Streed Jr C, et al.
Arch Sex Behav
. 2024 Nov;
54(2):817-826.
PMID: 39485606
Transgender and gender diverse (TGD) individuals represent a population with a heavy burden of HIV. Multi-level stigma encountered by TGD individuals can create significant barriers to discussing topics related to...